Literature DB >> 8380617

Small deletion and insertion mutations induced by the topoisomerase II inhibitor teniposide in CHO cells and comparison with sites of drug-stimulated DNA cleavage in vitro.

Y H Han1, M J Austin, Y Pommier, L F Povirk.   

Abstract

Sixty-five teniposide-induced mutations at the hemizygous aprt locus of CHO D422 cells were analyzed by polymerase chain reaction and DNA sequencing. Most (63%) of the mutations were deletions, duplications and insertions of various sizes, with the majority being less than 20 base-pairs. The remaining mutations were base substitutions, the majority of which were transversions. A significant correspondence was found between the teniposide-induced small deletion/duplication mutations and sites of teniposide-stimulated DNA strand cleavage by topoisomerase II in vitro. In particular, sequences which were deleted in one or more of the mutants showed a much higher incidence of strong cleavage sites than sequences not involved in deletions. However, the exact positioning of the cleavage sites with respect to the deletion termini was variable. The data did not suggest any unified model to account for all the mutations, but most of the deletions and duplications could be accounted for by one of three mechanisms: (1) double-strand break repair nonhomologous end-joining; (2) replication slippage/misalignment; and (3) addition or deletion of a few nucleotides at free 3' ends left by topoisomerase II, as previously suggested for similar mutations in phage T4. There was no evidence that topoisomerase II subunit exchange was a significant mechanism of mutagenesis in this system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380617     DOI: 10.1006/jmbi.1993.1007

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  The PKZ1 recombination mutation assay: a sensitive assay for low dose studies.

Authors:  P J Sykes; A A Morley; A M Hooker
Journal:  Dose Response       Date:  2006-08-19       Impact factor: 2.658

2.  Transposition without transposase: a spontaneous mutation in bacteria.

Authors:  C A Rappleye; J R Roth
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

3.  3'-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends.

Authors:  D Suh; D M Wilson; L F Povirk
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

4.  Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei.

Authors:  I I Gromova; B Thomsen; S V Razin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

Review 5.  Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes.

Authors:  N Osheroff; A H Corbett; S H Elsea; M Westergaard
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Loss of drug-stimulated topoisomerase II DNA breaks in living cells is different at two unrelated loci.

Authors:  M Binaschi; M E Borgnetto; G Capranico
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

7.  Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.

Authors:  Q Wang; G P Zambetti; D P Suttle
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

Review 8.  Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

Authors:  María Sol Brassesco; Danilo Jordão Xavier; Marjori Leiva Camparoto; Ana Paula Montaldi; Paulo Roberto D'Auria Vieira de Godoy; Carlos Alberto Scrideli; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo
Journal:  J Biomed Biotechnol       Date:  2010-08-31

9.  Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.

Authors:  Michelle Sabourin; John L Nitiss; Karin C Nitiss; Kazuo Tatebayashi; Hideo Ikeda; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

10.  Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.

Authors:  A Tanizawa; K W Kohn; Y Pommier
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.